Works matching AU Landovitz, Raphael J.

Results: 81
    1
    2
    3

    PRE-EXPOSURE PROPHYLAXIS PRODUCT CHOICE IN US PARTICIPANTS IN HPTN 083.

    Published in:
    Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 397
    By:
    • Clement, Meredith E.;
    • Zhe Wang;
    • Fichtenbaum, Carl J.;
    • Thomas, Schuyler;
    • Bazan, Jose A.;
    • Richardson, Paul;
    • Spinelli, Matthew A.;
    • Hanscom, Brett;
    • Rinehart, Alex R.;
    • Rooney, Jim;
    • Adeyeye, Adeola;
    • McCauley, Marybeth;
    • Cohen, Myron S.;
    • Grinsztejn, Beatriz;
    • Landovitz, Raphael J.
    Publication type:
    Article
    4

    BONE DENSITY CHANGES WITH CAB-LA OR TDF/FTC PrEP IN MSM AND TGW IN HPTN 083.

    Published in:
    Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 395
    By:
    • Brown, Todd T.;
    • Arao, Robert;
    • Phanuphak, Nittaya;
    • Kallas, Esper;
    • Oyedele, Tomitope;
    • Berman, Richard;
    • Sullivan, Philip;
    • Hanscom, Brett;
    • Adeyeye, Adeola;
    • Rooney, Jim;
    • Rinehart, Alex R.;
    • Jennings, Andrea;
    • McCauley, Marybeth;
    • Grinsztejn1, Beatriz;
    • Landovitz, Raphael J.
    Publication type:
    Article
    5
    6

    THE LEVI SYNDROME: CHARACTERISTICS OF EARLY HIV INFECTION WITH CABOTEGRAVIR FOR PrEP.

    Published in:
    Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 66
    By:
    • Eshleman, Susan H.;
    • Fogel, Jessica M.;
    • Piwowar-Manning, Estelle;
    • Hanscom, Brett;
    • Rinehart, Alex R.;
    • Cohen, Myron S.;
    • McCauley, Marybeth;
    • Farrior, Jennifer;
    • Adeyeye, Adeola;
    • Hosseinipour, Mina;
    • Grinsztejn, Beatriz;
    • Marzinke, Mark A.;
    • Delany-Moretlwe, Sinead;
    • Landovitz, Raphael J.
    Publication type:
    Article
    7
    8
    9

    Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.

    Published in:
    Journal of the International AIDS Society, 2025, v. 28, n. 1, p. 1, doi. 10.1002/jia2.26401
    By:
    • Delany‐Moretlwe, Sinead;
    • Hanscom, Brett;
    • Guo, Xu;
    • Nkabiito, Clemensia;
    • Mandima, Patricia;
    • Nahirya, Patricia Ntege;
    • Mpendo, Juliet;
    • Bhondai‐Mhuri, Muchaneta;
    • Mgodi, Nyaradzo;
    • Berhanu, Rebecca;
    • Farrior, Jennifer;
    • Piwowar‐Manning, Estelle;
    • Ford, Susan L.;
    • Hendrix, Craig W.;
    • Rinehart, Alex R.;
    • Rooney, James F.;
    • Adeyeye, Adeola;
    • Landovitz, Raphael J.;
    • Cohen, Myron S.;
    • Hosseinipour, Mina C.
    Publication type:
    Article
    10

    Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions.

    Published in:
    Journal of the International AIDS Society, 2019, v. 22, n. 3, p. N.PAG, doi. 10.1002/jia2.25247
    By:
    • Amico, K Rivet;
    • Ramirez, Catalina;
    • Caplan, Margaret R;
    • Montgomery, Brooke EE;
    • Stewart, Jennifer;
    • Hodder, Sally;
    • Swaminathan, Shobha;
    • Wang, Jing;
    • Darden‐Tabb, Noshima Y;
    • McCauley, Marybeth;
    • Mayer, Kenneth H;
    • Wilkin, Timothy;
    • Landovitz, Raphael J;
    • Gulick, Roy;
    • Adimora, Adaora A
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 7, p. 609, doi. 10.1001/jama.2024.24543
    By:
    • Gandhi, Rajesh T.;
    • Landovitz, Raphael J.;
    • Sax, Paul E.;
    • Smith, Davey M.;
    • Springer, Sandra A.;
    • Günthard, Huldrych F.;
    • Thompson, Melanie A.;
    • Bedimo, Roger J.;
    • Benson, Constance A.;
    • Buchbinder, Susan P.;
    • Crabtree-Ramirez, Brenda E.;
    • del Rio, Carlos;
    • Eaton, Ellen F.;
    • Eron Jr, Joseph J.;
    • Hoy, Jennifer F.;
    • Lehmann, Clara;
    • Molina, Jean-Michel;
    • Jacobsen, Donna M.;
    • Saag, Michael S.
    Publication type:
    Article
    18
    19
    20
    21

    Protocol for a randomized controlled trial with a stepped care approach, utilizing PrEP navigation with and without contingency management, for transgender women and sexual minority men with a substance use disorder: Assistance Services Knowledge-PrEP (A.S.K.-PrEP)

    Published in:
    Addiction Science & Clinical Practice, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13722-024-00482-6
    By:
    • Reback, Cathy J.;
    • Landovitz, Raphael J.;
    • Benkeser, David;
    • Jalali, Ali;
    • Shoptaw, Steven;
    • Li, Michael J.;
    • Mata, Raymond P.;
    • Ryan, Danielle;
    • Jeng, Philip J.;
    • Murphy, Sean M.
    Publication type:
    Article
    22
    23
    24

    Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.

    Published in:
    Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1842, doi. 10.1093/cid/civ193
    By:
    • Ofotokun, Ighovwerha;
    • Na, Lumine H.;
    • Landovitz, Raphael J.;
    • Ribaudo, Heather J.;
    • McComsey, Grace A.;
    • Godfrey, Catherine;
    • Aweeka, Francesca;
    • Cohn, Susan E.;
    • Sagar, Manish;
    • Kuritzkes, Daniel R.;
    • Brown, Todd T.;
    • Patterson, Kristine B.;
    • Para, Michael F.;
    • Leavitt, Randi Y.;
    • Villasis-Keever, Angelina;
    • Baugh, Bryan P.;
    • Lennox, Jeffrey L.;
    • Currier, Judith S.
    Publication type:
    Article
    25

    Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.

    Published in:
    Clinical Infectious Diseases, 2015, v. 60, n. 12, p. 1842, doi. 10.1093/cid/civ193
    By:
    • Ofotokun, Ighovwerha;
    • Na, Lumine H.;
    • Landovitz, Raphael J.;
    • Ribaudo, Heather J.;
    • McComsey, Grace A.;
    • Godfrey, Catherine;
    • Aweeka, Francesca;
    • Cohn, Susan E.;
    • Sagar, Manish;
    • Kuritzkes, Daniel R.;
    • Brown, Todd T.;
    • Patterson, Kristine B.;
    • Para, Michael F.;
    • Leavitt, Randi Y.;
    • Villasis-Keever, Angelina;
    • Baugh, Bryan P.;
    • Lennox, Jeffrey L.;
    • Currier, Judith S.
    Publication type:
    Article
    26

    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

    Published in:
    PLoS Medicine, 2018, v. 15, n. 11, p. 1, doi. 10.1371/journal.pmed.1002690
    By:
    • Landovitz, Raphael J.;
    • Li, Sue;
    • Grinsztejn, Beatriz;
    • Dawood, Halima;
    • Liu, Albert Y.;
    • Magnus, Manya;
    • Hosseinipour, Mina C.;
    • Panchia, Ravindre;
    • Cottle, Leslie;
    • Chau, Gordon;
    • Richardson, Paul;
    • Marzinke, Mark A.;
    • Hendrix, Craig W.;
    • Eshleman, Susan H.;
    • Zhang, Yinfeng;
    • Tolley, Elizabeth;
    • Sugarman, Jeremy;
    • Kofron, Ryan;
    • Adeyeye, Adeola;
    • Burns, David
    Publication type:
    Article
    27

    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

    Published in:
    PLoS Medicine, 2018, v. 15, n. 11, p. 1, doi. 10.1371/journal.pmed.1002690
    By:
    • Landovitz, Raphael J.;
    • Li, Sue;
    • Grinsztejn, Beatriz;
    • Dawood, Halima;
    • Liu, Albert Y.;
    • Magnus, Manya;
    • Hosseinipour, Mina C.;
    • Panchia, Ravindre;
    • Cottle, Leslie;
    • Chau, Gordon;
    • Richardson, Paul;
    • Marzinke, Mark A.;
    • Hendrix, Craig W.;
    • Eshleman, Susan H.;
    • Zhang, Yinfeng;
    • Tolley, Elizabeth;
    • Sugarman, Jeremy;
    • Kofron, Ryan;
    • Adeyeye, Adeola;
    • Burns, David
    Publication type:
    Article
    28

    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

    Published in:
    2018
    By:
    • Landovitz, Raphael J;
    • Li, Sue;
    • Grinsztejn, Beatriz;
    • Dawood, Halima;
    • Liu, Albert Y;
    • Magnus, Manya;
    • Hosseinipour, Mina C;
    • Panchia, Ravindre;
    • Cottle, Leslie;
    • Chau, Gordon;
    • Richardson, Paul;
    • Marzinke, Mark A;
    • Hendrix, Craig W;
    • Eshleman, Susan H;
    • Zhang, Yinfeng;
    • Tolley, Elizabeth;
    • Sugarman, Jeremy;
    • Kofron, Ryan;
    • Adeyeye, Adeola;
    • Burns, David
    Publication type:
    journal article
    29
    30

    Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.

    Published in:
    2021
    By:
    • Barnabas, Ruanne V.;
    • Brown, Elizabeth R.;
    • Bershteyn, Anna;
    • Stankiewicz Karita, Helen C.;
    • Johnston, Christine;
    • Thorpe, Lorna E.;
    • Kottkamp, Angelica;
    • Neuzil, Kathleen M.;
    • Laufer, Miriam K.;
    • Deming, Meagan;
    • Paasche-Orlow, Michael K.;
    • Kissinger, Patricia J.;
    • Luk, Alfred;
    • Paolino, Kristopher;
    • Landovitz, Raphael J.;
    • Hoffman, Risa;
    • Schaafsma, Torin T.;
    • Krows, Meighan L.;
    • Thomas, Katherine K.;
    • Morrison, Susan
    Publication type:
    journal article
    31

    Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.

    Published in:
    2017
    By:
    • Gulick, Roy M.;
    • Wilkin, Timothy J.;
    • Chen, Ying Q.;
    • Landovitz, Raphael J.;
    • Amico, K. Rivet;
    • Young, Alicia M.;
    • Richardson, Paul;
    • Marzinke, Mark A.;
    • Hendrix, Craig W.;
    • Eshleman, Susan H.;
    • McGowan, Ian;
    • Cottle, Leslie M.;
    • Andrade, Adriana;
    • Marcus, Cheryl;
    • Klingman, Karin L.;
    • Chege, Wairimu;
    • Rinehart, Alex R.;
    • Rooney, James F.;
    • Andrew, Philip;
    • Salata, Robert A.
    Publication type:
    journal article
    32

    Novel Antiretroviral Agents.

    Published in:
    Current HIV/AIDS Reports, 2020, v. 17, n. 2, p. 118, doi. 10.1007/s11904-020-00486-2
    By:
    • Cambou, Mary C.;
    • Landovitz, Raphael J.
    Publication type:
    Article
    33
    34
    35

    Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.

    Published in:
    JAMA Pediatrics, 2017, v. 171, n. 11, p. 1063, doi. 10.1001/jamapediatrics.2017.2007
    By:
    • Hosek, Sybil G.;
    • Landovitz, Raphael J.;
    • Kapogiannis, Bill;
    • Siberry, George K.;
    • Rudy, Bret;
    • Rutledge, Brandy;
    • Liu, Nancy;
    • Harris, D. Robert;
    • Mulligan, Kathleen;
    • Zimet, Gregory;
    • Mayer, Kenneth H.;
    • Anderson, Peter;
    • Kiser, Jennifer J.;
    • Lally, Michelle;
    • Brothers, Jennifer;
    • Bojan, Kelly;
    • Rooney, Jim;
    • Wilson, Craig M.
    Publication type:
    Article
    36
    37
    38
    39

    Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

    Published in:
    2014
    By:
    • Lennox, Jeffrey L;
    • Landovitz, Raphael J;
    • Ribaudo, Heather J;
    • Ofotokun, Ighovwerha;
    • Na, Lumine H;
    • Godfrey, Catherine;
    • Kuritzkes, Daniel R;
    • Sagar, Manish;
    • Brown, Todd T;
    • Cohn, Susan E;
    • McComsey, Grace A;
    • Aweeka, Francesca;
    • Fichtenbaum, Carl J;
    • Presti, Rachel M;
    • Koletar, Susan L;
    • Haas, David W;
    • Patterson, Kristine B;
    • Benson, Constance A;
    • Baugh, Bryan P;
    • Leavitt, Randi Y
    Publication type:
    journal article
    40

    Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1.

    Published in:
    Annals of Internal Medicine, 2014, v. 161, n. 7, p. 461, doi. 10.7326/M14-1084
    By:
    • Lennox, Jeffrey L.;
    • Landovitz, Raphael J.;
    • Ribaudo, Heather J.;
    • Ofotokun, Ighovwerha;
    • Na, Lumine H.;
    • Godfrey, Catherine;
    • Kuritzkes, Daniel R.;
    • Sagar, Manish;
    • Brown, Todd T.;
    • Cohn, Susan E.;
    • McComsey, Grace A.;
    • Aweeka, Francesca;
    • Fichtenbaum, Carl J.;
    • Presti, Rachel M.;
    • Koletar, Susan L.;
    • Haas, David W.;
    • Patterson, Kristine B.;
    • Benson, Constance A.;
    • Baugh, Bryan P.;
    • Leavitt, Randi Y.
    Publication type:
    Article
    41
    42
    43
    44
    45

    Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV.

    Published in:
    Global Health: Science & Practice, 2023, v. 11, n. 2, p. 1, doi. 10.9745/GHSP-D-22-00401
    By:
    • Ruel, Theodore;
    • Penazzato, Martina;
    • Zech, Jennifer M.;
    • Archary, Moherndran;
    • Cressey, Tim R.;
    • Goga, Ameena;
    • Harwell, Joseph;
    • Landovitz, Raphael J.;
    • Lain, Maria Grazia;
    • Lallemant, Marc;
    • Namusoke-Magongo, Eleanor;
    • Mukui, Irene;
    • Permar, Sallie R.;
    • Prendergast, Andrew J.;
    • Shapiro, Roger;
    • Abrams, Elaine J.
    Publication type:
    Article
    46
    47

    Using time‐weighted average change from baseline of SARS‐CoV‐2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID‐19.

    Published in:
    Journal of Medical Virology, 2022, v. 94, n. 12, p. 6091, doi. 10.1002/jmv.28054
    By:
    • Kumbhakar, Raaka;
    • Neradilek, Moni;
    • Barnabas, Ruanne V.;
    • Stewart, Jenell;
    • Stankiewicz Karita, Helen C.;
    • Landovitz, Raphael J.;
    • Kissinger, Patricia J.;
    • Jerome, Keith R.;
    • Paasche‐Orlow, Michael K.;
    • Bershteyn, Anna;
    • Chu, Helen Y.;
    • Neuzil, Kathleen M.;
    • Greninger, Alexander L.;
    • Luk, Alfred;
    • Wald, Anna;
    • Brown, Elizabeth R.;
    • Johnston, Christine
    Publication type:
    Article
    48
    49
    50

    Population pharmacokinetics of cabotegravir following administration of oral tablet and long‐acting intramuscular injection in adult HIV‐1‐infected and uninfected subjects.

    Published in:
    British Journal of Clinical Pharmacology, 2022, v. 88, n. 10, p. 4607, doi. 10.1111/bcp.15439
    By:
    • Han, Kelong;
    • Baker, Mark;
    • Lovern, Mark;
    • Paul, Prokash;
    • Xiong, Yuan;
    • Patel, Parul;
    • Moore, Katy P.;
    • Seal, Ciara S.;
    • Cutrell, Amy G.;
    • D'Amico, Ronald D.;
    • Benn, Paul D.;
    • Landovitz, Raphael J.;
    • Marzinke, Mark A.;
    • Spreen, William R.;
    • Ford, Susan L.
    Publication type:
    Article